Evidence map›Paper›PMID 40788302›Full record

ArticleeLife2025

A biofilm-tropic

Brenna Walton, Serena Abbodante, Michaela Ellen Marshall, Justyna M Dobruchowska, Amani Alvi, Larry A Gallagher, Nikhil Vallikat, Zhemin Zhang, Daniel J Wozniak, Edward W Yu and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Complementary killing activities ofAntimicrobial agents and chemotherapy · 2025
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Brenna WaltonDepartment of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, United States.
Serena AbbodanteDepartment of Ophthalmology, University of California, Irvine, Irvine, United States.
Michaela Ellen MarshallDepartment of Ophthalmology, University of California, Irvine, Irvine, United States.ORCID https://orcid.org/0000-0001-9381-780X
Justyna M DobruchowskaDepartment of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, Netherlands.
Amani AlviDepartment of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, United States.
Larry A GallagherDepartment of Microbiology, University of Washington, Seattle, United States.
Nikhil VallikatDepartment of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, United States.
Zhemin ZhangDepartment of Pharmacology, Case Western Reserve University, Cleveland, United States.
Daniel J WozniakDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, United States.
Edward W YuDepartment of Pharmacology, Case Western Reserve University, Cleveland, United States.
Geert-Jan BoonsDepartment of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, Netherlands.
Eric PearlmanDepartment of Ophthalmology, University of California, Irvine, Irvine, United States.ORCID https://orcid.org/0000-0003-0137-7582
Arne RietschDepartment of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, United States.ORCID https://orcid.org/0000-0002-1556-7064

Funding

Research Support Core D: Clinical and Behavioral ServicesP30DA054557 · NIDA · CASE WESTERN RESERVE UNIVERSITY · PI LEVINE, ALAN DAVID · 2021 to 2025
$16.2M
Toll Like Receptors in Bacterial KeratitisR01EY014362 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI GEORGE R DUBYAK, Eric Pearlman · 2003 to 2026
$8.7M
The impact of bacteriophage therapy on wound infection dynamicsR01AI169865 · NIAID · OHIO STATE UNIVERSITY · PI Daniel J Wozniak · 2022 to 2026
$3.7M
Emerging antibiotic resistance in Gram-negative pathogensR01AI145069 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI YU, EDWARD W · 2019 to 2023
$3.3M
NEI NIH HHS R01 EY014362NIAID NIH HHS R01 AI145069NIAID NIH HHS R01 AI169865NIDA NIH HHS P30 DA054557NIH HHS R01AI145069NIH HHS R01AI169865NIH HHS R01EY14362
6 · The paper itself

Abstract

Bacteria in nature can exist in multicellular communities called biofilms. Biofilms also form in the course of many infections.

Indexed as

BiofilmsPolysaccharides, BacterialPseudomonas aeruginosaPseudomonas PhagesReceptors, VirusAnimalsMicePseudomonas Infectionsexopolysaccharide, PseudomonasPolysaccharides, BacterialReceptors, Virusbacteriophagebiofilm matrixBruynoghevirusexopolysaccharideinfectious diseasemicrobiologyPseudomonasviruses

Identifiers

PMID40788302
PMCPMC12339003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.